A Study in Patients with Hard-to-Heal Venous Leg Ulcers to Measure Efficacy and Safety of Locally Administered LL-37; A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre Trial
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2018
At a glance
- Drugs LL 37 (Primary)
- Indications Leg ulcer; Varicose ulcer
- Focus Therapeutic Use
- Acronyms HEAL LL-37
- 20 Oct 2018 Planned number of patients changed from 120 to 159.
- 01 Oct 2018 According to a ProMore Pharma media release, first patient has been enrolled in this trial.
- 01 Oct 2018 Status changed from planning to recruiting, as reported in the ProMore Pharma media release.